MedAvail Holdings, Inc. Common Stock
MDVL
MDVL was delisted on the 12th of February, 2024.
10 hedge funds and large institutions have $519K invested in MedAvail Holdings, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
11% more funds holding
Funds holding: 9 → 10 (+1)
2% more capital invested
Capital invested by funds: $507K → $519K (+$12K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.3K |
| 2 |
Barclays
London,
United Kingdom
|
+$11.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.76K |
MDVL Hedge Fund Activity: Q2 2020 in Review
10 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q2 2020, worth a combined $519K — up 2.4% from $507K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MDVL positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, adding an estimated $19.3K. The largest seller was UBS Group, cutting an estimated $1.76K.
- 10 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q2 2020, up from 9 in Q1 2020.
- Funds reported $519K of MedAvail Holdings, Inc. Common Stock stock for Q2 2020, up 2.4% quarter-over-quarter.
- 1 fund opened new MedAvail Holdings, Inc. Common Stock positions in Q2 2020 and 0 closed out, a net change of +1 holder.
- The largest MedAvail Holdings, Inc. Common Stock buyer in Q2 2020 was Vanguard Group, an estimated $19.3K added.
- The largest MedAvail Holdings, Inc. Common Stock seller in Q2 2020 was UBS Group, an estimated $1.76K sold.
Based on aggregated 13F filings for Q2 2020.